Chronic neutrophilic leukemia historical perspective: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964. WHO introduced the criteria for the diagnosis of this disease as a myeloproliferative disorder in 2001. In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients and made a huge change in diagnosis and treatment of this patient. | Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of [[splenomegaly]] and neutrophilic [[leukocytosis]], in 1920. Although, It was named by Tanzer et al, in 1964. [[World Health Organization|WHO]] introduced the [[criteria]] for the [[diagnosis]] of this disease as a [[Myeloproliferative neoplasm|myeloproliferative disorder]] in 2001. In 2013, [[CSF3R]] (colony stimulating factor 3 receptor) [[Mutation|mutations]] was proposed that was found in the most CNL patients and made a huge change in [[diagnosis]] and treatment of this patient. | ||
==Historical Perspective== | ==Historical Perspective== | ||
===Discovery=== | ===Discovery=== | ||
* Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. | * Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of [[splenomegaly]] and neutrophilic [[leukocytosis]], in 1920.Although, It was named by Tanzer et al, in 1964. | ||
* In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016. | * In 2001, [[World Health Organization|WHO]] introduced the [[criteria]] for diagnosis CNL as a [[Myeloproliferative neoplasm|myeloproliferative disorder]] that was revised in 2016. | ||
* In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients. | * In 2013, [[CSF3R]] (colony stimulating factor 3 receptor) [[Mutation|mutations]] was proposed that was found in the most CNL [[Patient|patients]]. | ||
==References== | ==References== | ||
[[Category:Medicine]][[Category:Oncology]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | |||
<references /> | |||
Revision as of 16:30, 21 January 2019
|
Chronic neutrophilic leukemia Microchapters |
|
Differentiating Chronic neutrophilic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic neutrophilic leukemia historical perspective On the Web |
|
American Roentgen Ray Society Images of Chronic neutrophilic leukemia historical perspective |
|
Chronic neutrophilic leukemia historical perspective in the news |
|
Blogs on Chronic neutrophilic leukemia historical perspective |
|
Directions to Hospitals Treating Chronic neutrophilic leukemia |
|
Risk calculators and risk factors for Chronic neutrophilic leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964. WHO introduced the criteria for the diagnosis of this disease as a myeloproliferative disorder in 2001. In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients and made a huge change in diagnosis and treatment of this patient.
Historical Perspective
Discovery
- Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920.Although, It was named by Tanzer et al, in 1964.
- In 2001, WHO introduced the criteria for diagnosis CNL as a myeloproliferative disorder that was revised in 2016.
- In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients.